Luis Rojas

1.1k total citations
48 papers, 636 citations indexed

About

Luis Rojas is a scholar working on Hematology, Surgery and Oncology. According to data from OpenAlex, Luis Rojas has authored 48 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Surgery and 9 papers in Oncology. Recurrent topics in Luis Rojas's work include Acute Myeloid Leukemia Research (11 papers), Drug Transport and Resistance Mechanisms (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). Luis Rojas is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Drug Transport and Resistance Mechanisms (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). Luis Rojas collaborates with scholars based in Chile, Spain and United States. Luis Rojas's co-authors include Marí­a José Herrero, Salvador F. Aliño, José Luís Poveda, Virginia Bosó, Juan Eduardo Megías‐Vericat, Craig Goolsby, Miguel Á. Sanz, Federico Moscardó, Pau Montesinos and Matthew J. Levy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Luis Rojas

46 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Rojas Chile 16 136 128 122 113 111 48 636
Isabelle Tostivint France 12 93 0.7× 85 0.7× 42 0.3× 117 1.0× 72 0.6× 28 645
Maite Rivera Spain 20 62 0.5× 413 3.2× 278 2.3× 76 0.7× 109 1.0× 126 1.5k
Nancy Reau United States 20 101 0.7× 185 1.4× 34 0.3× 55 0.5× 36 0.3× 110 1.4k
Rachel Hilton United Kingdom 18 181 1.3× 138 1.1× 213 1.7× 52 0.5× 52 0.5× 52 793
Chi Yuen Cheung China 16 246 1.8× 189 1.5× 328 2.7× 163 1.4× 78 0.7× 77 938
A. Bren Slovenia 16 54 0.4× 159 1.2× 132 1.1× 79 0.7× 13 0.1× 62 697
Rubina Naqvi Pakistan 14 40 0.3× 334 2.6× 354 2.9× 50 0.4× 26 0.2× 61 1.0k
Jacqueline van de Wetering Netherlands 19 91 0.7× 417 3.3× 594 4.9× 176 1.6× 19 0.2× 95 1.3k
June Fabian South Africa 18 56 0.4× 115 0.9× 73 0.6× 99 0.9× 180 1.6× 91 983
Himanshu V. Patel India 15 46 0.3× 243 1.9× 258 2.1× 44 0.4× 39 0.4× 110 815

Countries citing papers authored by Luis Rojas

Since Specialization
Citations

This map shows the geographic impact of Luis Rojas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Rojas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Rojas more than expected).

Fields of papers citing papers by Luis Rojas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Rojas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Rojas. The network helps show where Luis Rojas may publish in the future.

Co-authorship network of co-authors of Luis Rojas

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Rojas. A scholar is included among the top collaborators of Luis Rojas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Rojas. Luis Rojas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Barrera, Manuel, et al.. (2023). Validation of the CALL score as a mortality prediction tool in a cohort of hospitalized COVID-19 patients in Chile. Frontiers in Medicine. 10. 1164615–1164615. 3 indexed citations
3.
S, Luz María Letelier, et al.. (2023). Is Acetaminophen Beneficial in Patients With Cancer Pain Who are on Strong Opioids? A Randomized Controlled Trial. Journal of Pain and Symptom Management. 66(3). 183–192.e1. 7 indexed citations
4.
Zebboudj, Abderezak, Masataka Amisaki, Pablo Guasp, et al.. (2022). 1312 Gut dysbiosis suppresses anti-tumor ILC2s in pancreatic cancer. Regular and Young Investigator Award Abstracts. A1363–A1363. 1 indexed citations
6.
Vera, Magdalena, Eduardo Kattan, Bárbara Lara, et al.. (2021). Intubation timing as determinant of outcome in patients with acute respiratory distress syndrome by SARS-CoV-2 infection. Journal of Critical Care. 65. 164–169. 23 indexed citations
8.
Goolsby, Craig, et al.. (2020). High-School Students Can Stop the Bleed: A Randomized, Controlled Educational Trial. Academic Pediatrics. 21(2). 321–328. 22 indexed citations
9.
Serrano, Carolina, Luis A. Quiñones, Paul R. Harris, et al.. (2019). High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis. Scientific Reports. 9(1). 20070–20070. 31 indexed citations
10.
Dawson, Jill, et al.. (2019). Use of Big Data to Aid Patient Recruitment for Clinical Trials Involving Biosimilars and Rare Diseases. Therapeutic Innovation & Regulatory Science. 54(4). 870–877. 3 indexed citations
11.
Ferrer, Juan‐Carlos, et al.. (2018). A proactive transfer policy for critical patient flow management. Health Care Management Science. 22(2). 287–303. 20 indexed citations
12.
Megías‐Vericat, Juan Eduardo, Luis Rojas, Marí­a José Herrero, et al.. (2015). Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies. The Pharmacogenomics Journal. 15(2). 109–118. 26 indexed citations
13.
Megías‐Vericat, Juan Eduardo, Marí­a José Herrero, Luis Rojas, et al.. (2015). A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia. The Pharmacogenomics Journal. 16(1). 30–40. 9 indexed citations
14.
Rojas, Luis, Marí­a José Herrero, Virginia Bosó, et al.. (2013). Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation. Pharmacogenetics and Genomics. 23(10). 509–517. 24 indexed citations
15.
P, Fernando Saldías, et al.. (2011). Metodología de adaptación de una guía clínica para el manejo de pacientes adultos con neumonía adquirida en la comunidad en una red de salud privada. Revista médica de Chile. 139(11). 1403–1413. 3 indexed citations
16.
Vásquez, Julio C., et al.. (2008). Severe Mitral Regurgitation and Hepatopulmonary Hydatid Cysts: What Should Be Treated First?. Journal of Tropical Pediatrics. 54(6). 420–421. 1 indexed citations
17.
Rojas, Luis, et al.. (2007). Retos y contradicciones de la industria biotecnológica actual. Biotecnología aplicada. 24. 276–282. 1 indexed citations
18.
Rojas, Luis, et al.. (2006). Mortalidad materna. Análisis. 10(1). 26–30. 5 indexed citations
19.
Rojas, Luis, et al.. (2006). Enfermedad por arañazo de gato: Características clínicas y de laboratorio en pacientes adultos hospitalizados por fiebre o adenopatías. Revista médica de Chile. 134(10). 1243–8. 3 indexed citations
20.
Rojas, Luis, et al.. (2006). Integron presence in a multiresistant Morganella morganii isolate. International Journal of Antimicrobial Agents. 27(6). 505–512. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026